- Poland
- /
- Healthcare Services
- /
- WSE:EMC
EMC Instytut Medyczny Third Quarter 2023 Earnings: EPS: zł0.085 (vs zł0.018 in 3Q 2022)
EMC Instytut Medyczny (WSE:EMC) Third Quarter 2023 Results
Key Financial Results
- Revenue: zł181.9m (up 20% from 3Q 2022).
- Net income: zł3.54m (up 375% from 3Q 2022).
- Profit margin: 1.9% (up from 0.5% in 3Q 2022). The increase in margin was driven by higher revenue.
- EPS: zł0.085 (up from zł0.018 in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
EMC Instytut Medyczny's share price is broadly unchanged from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. See our latest analysis on EMC Instytut Medyczny's balance sheet health.
Valuation is complex, but we're here to simplify it.
Discover if EMC Instytut Medyczny might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:EMC
Proven track record with adequate balance sheet.